Two healthcare Dow stocks stunned investors with their sharp falls in May. The worst-performing Dow stock last month plunged ...

Despite a $258 million deficit, the city of San Diego still averages over $6K per day to maintain the vacant 101 Ash Street building.

In the U.S., it is estimated there will be approximately 72,680 new cases of head and neck cancer diagnosed and more than ...

Merck's Keytruda receives FDA approval for head and neck cancer after showing improved event-free survival in Phase 3 KEYNOTE ...

Sly & The Family Stone's "Family Affair" saw a splintering band reach the highest heights of pop music one last time.

Germany’s Merck KGaA has presented detailed results from cohort B of the global Phase II WILLOW study of enpatoran, an ...

BMY's banks on label expansion of drugs like Sotyktu and Opdivo to boost sales in the wake of generic competition for legacy ...

Citizens Financial Group (CFG) will be expanding its share buyback program to $1.5 billion. Pharmaceutical giant Merck (MRK) received approval from the US Food and Drug Administration (FDA) to use ...

Merck & Co. Inc. closed 39.23% short of its 52-week high of $134.63, which the company reached on June 25th.

One of the new vaccine advisers picked by U.S. Health Secretary Robert F. Kennedy Jr. has earned thousands of dollars as an ...

One of the new members to the CDC's vaccine advisory panel has served as an expert witness in a case against Merck's (MRK) ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the MOBILIZE-1 Phase 3 clinical trial evaluating the safety, immunogenicity and efficacy of a ...